had been vaccinated previously with CVI-78 and 73% of those vaccinated previously with standard calf lymph. All children in both groups had a vesicular reaction either after the first or the second vaccination. Likewise, all children had a positive HI titer. On the other hand, only 65% of those children initially vaccinated with CVI-78 vaccine had positive neutralizing antibodies after revaccination, whereas a11 children who received standard calf lymph both times had positive neutralizing antibodies. Nineteen percent of the CVI-78 group had no HI or neutrali~ing antibodies after primary vaccination. All of these children responded as primary vaccinees on challenge with standard calf lymph. The number of vaccinations in this trial is insufficient to determine to what degree vaccination with CVI-78 will reduce the incidence of complications associated with smallpox vaccine.
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Phenylalanine Hydroxylase Activity in Liver
Biopsies from Hyperphenylalaninemia Heterozygotes: Deviation from Proportionality with Gene Dosage
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Extract Liver biopsy samples from the patients with hyperphenylalaninemia have an average of 5% of the normal hydroxylase activity. The parents of the patients have between 7.3% (excluding the value for one parent) and 10% of the normal hepatic hydroxylase activity. An explanation for these findings involves negative interallelic complementation, which involves protein-protein interaction between subunits in a multimeric enzyme. In support of this model is the evidence that rat liver phenylalanine hydroxylase is a multimeric protein composed of two electrophoretically distinguishable subunits.
Speculation
The finding that parents of patients with hyperphenylalaninemia have an average of 10% of the normal level of hepatic phenylalanine hydroxylase, a multimeric enzyme, can be explained on the assumption that the liver tissue of heterozygotes has an excess of enzyme molecules that contain at least one mutant subunit.
Widespread screening of neonates for phenylketonuria ( P K U ) has in recent years brought to light a class of patients with an apparently milder defect in phenylalanine metabolism than is seen in classic P K U . These patients are characterized by serum phenylalanine concentrations which are well below the concentrations in PKU serum, but still severalfold higher than normal (8) . The condition has therefore been called hyperphenylalaninetnia. The patients can be distinguished from PKU heterorygotes, and their pedigrees suggest autosomal recessive genetics (IS).
In this laboratory, a series of liver biopsies from several hyperphenylalaninemic patients was shown by direct enzyme assay to have about 5% of the normal phenylalanine hydroxylase activit! of human livcr (9. 1 1 ) . As part of that study, the hydroxyliise activity o f t h e parents of three hyperphenylalnnine~i~ic children was also assayed with the identical technique, hut the results were not reported (except for one set ofparents, see Reference 9 ) because no conclusive interpretation could be made at that time. Although our interpretations must still he tentative, we would now like to present these data. since absolutely conclusive interpretation based on further experiments may not be forthcoming in the immediate future because of the unav;iilability of human liver ti.is11e for assay.
METHODS AND MATERIALS
The assay for phcnylalaninc hydrouylase wuh the same as that used previously (9-1 I ) . It is based on incubation ol' liver extracts with L-['4C]phenylalan~ne. a tetrahydropterin (2-amino-4-hydroxy-6.7-dilnethq.1 tetrahydropterin), a tetrahydropterinregenerating system (dihydropteridine reductase plus reduced pyridine nucleotide). and excess catalasc. The radioactivity in the ['Tltyrosinc that is formed is determined after separation of the tyrosine from the phen!lalanine bq paper chromatography. All reported hydrouylase-specific activities represent values that were repeated in several independent assays. They were all carried out under conditions in which the hydrox!l:isc activitj is proportional to protc~n concentration and time of incubation. In addition, during the course of K, determinations (4. 9. 1 I). most of the samples were assayed for hydroxylase activity at several diffrrent concentrations of either phenylalanine or pterin cofactor. Under all assay conditions. rhe relative hydroxqlase activities were similar to those reported in Table I . All materials Lfierc from sources that have been described previouslq (9 -1 I ).
RESULTS
The results summari/ed in Table I show that liver biopx! samples from the patients with hyperphenqlalaninemia have an average of 5' 5; of the normal hydroxylase activity. Although most of the control liver sunlplej were from patients with liver d~seasc. the last sample was from an accident victim: there is no indication this last value dil'krs from the others.
For the parents, thc values shou a considerable scatter. raising the possibility that they d o not constitute a homogeneous group. In particular. the relatively high hydroxhlase activit~ of filthc~r Kc. (3If% of the average control value) suggests that his genotype may be different from that of the other parents (in which case, the genotype of JKc, would also be diffrrent I'rom that of the other patients). It should be noted that the possibility that father K r is a nornial subject is unlikely, since we have found previously that both his fasting plasma phenylalanine levels and his phenqlalanine levels 4 hr after an oral phenylalanine load were elevated compared with values for normal control subjects (9) . All o f t h e other parents also showed signs of abnormal phenylalanine metabolism (either elevated plasma phenylalanine-to-tyrosine ratios or abnormally high phenylalanine levels after oral phenylalanine loading (9)).
Excluding farher K e from the group. the parents have an average of 7.3% of the normal hepatic hydrou>Iase activit!: including him, the average value is 10'7 of the normal. This low value for the parents is of considerable intereht, for although there have been other examples of heterorygotes with less than the expected 50f+ of normal activity. such as in cystathionine synthase deficiencq in which the heterorygotes have about 34V of the normal level o f t h e affected enzyme (2. 6. 14). and adenine phosphoribosyl trunsferase deficiency in which the heterorygotes have between 21 and 3 7 3 of the nornial activity (13) . in most other cases where enz!.nie activities have been assajed in i n d~v~d u a l s heteroz!gous for enzyme deficiencies, proportionalit) with gene dosage hiis been observed (7) . Therefore, if the hyperphenJlalaninemia patients synthesize a hydrouylase variant with 5% of the normal activity. one might expect the parents (presumablq heteroz~gotes) to show about 5 O q of the normal activit!. Unfortunately. it is possible that the low activities that we have observed in the heterozygotes could be related to the biopsy method: percutaneous needle biopsies were used for the piirents of the hyperphen~lalaninemia children, whereas for the children themselves. and for all nornial controlsubjecta, open biopsies were used. We have made one attempt to asscss the possible variation in hydroxqlase determinations which might result from the difference in biopsq methods: the hqdroxylase *;IS assayed in both needle and open biopsies taken froni a single dog. and the results were almost identical. In:~cccssibility of tissue precludes a direct experiment to determine uhether the same would in fact he true for human liver, but it seems unlikelq that this differential biopsy technique could completcl!~ account for the low hydro\ylase activity of the parents (16) .
In a single mixing experimcnt, the hydrox!lase activities of extracts from : I control liver sample and a h!perplienylalaninemia liver sample were shown to be additive. This result suggests that the deficiencq in hydroxqlasc activity observed in hyperphen!lalaninernia is not caused by the presence of inhibitors. I This value has been published prev~ousl\ (4) . The l~ver sample (I'rom an :icc~dent victim) was removed and frozen irnrnediatcly after death. We are grateful to Dr. E. LaBrosse for obtaining this liver sample.
Subjects
DISCUSSION
Apart from the possibilities of biopsy hias and enryme inhibitors. both of which seem remote, two other interpretations may explain the deviation from proportionalit! of activity with gene dosage in thc hctcrotygotes.
I . Regulator gene mutatlotis have been the basis of models
proposed in other cases of enzyme deficiencies in uhich heterozqgote uctivit! levels differed froni eipected balues. A g a~n s t this explanation for hyperphenjlulaninemia h e t c r o~g o t e s is the evidence that phenylalanine hldrox!lase in livers from hyperphenqlalaninernia patients is distinguishable from the normal en/!me in the following properties (4): ( 0 ) it has a lower apparent K,,, viilue for phenqlalanine in the presence of 6.7-dimethjItetriih!-dropterin: ( h ) its activity is stimulated less by Iysolecithin in the presence of the natural cofuctor. tetrahydrobiopterin: and ( c ) it appears to be somewhat more labile to heat inactivittion. These results suggest that the lou hydroxylase activity in hyperphen)lalaninernic patients is caused b) ;I mutation in the gene coding for the structure of the hqdroi!lase, rather than in u gene that regulates the rate of sjnthesis of the normal e n r l m e .
2. An alternative explanation nould involve negative intcrallelrc complementation. a phenomenon for which there is some precedent in microbial systems ( I ) , which involves protein-protein interiiction between subunits in a multtrneric enzqme. In order to
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evaluate this possibility, one must consider what is known about the structure of phenylalanine hydroxylase. There is evidence that rat liver phenylalanine hydroxylase is a multimeric protein coniposed of two electrophoretically distinguishable subunits (molecular weight between 51,000 and 55,000) (I?). In addition to the monomers, the enzyme exists as dimers (niol wt 110,000) and tetramers (niol wt 210,000) (12). It is not known with certainty, however. which forni is catalytically active. Nonetheless. the fact that the enzyme shows cooperative kinetic behavior (in the presence of tetrahydrobiopterin) (12) indicates strongly that a polymeric form of the enzyme is active. It is also known that limited proteolysis of the enzyme leads to a highly active form that can exist only as monomers and dimers (3). Since. as has already been mentioned. there is kinetic evidence that a polymeric form of the enzyme is active, this last finding indicates that the dinier is catalytically active.
With these considerations in mind, and on the assu~iiption that the structure of the human liver enzyme is essentially the same as the rat liver enzyme, the interallelic complementation niodel would lead to the following picture fc.r the phenotype of patients and their parents. According to this model, the normal hydroxylnse is a dimer composed of two different subunits, N and P. each subunit under the genetic control of an A locus and a B locus. The product of the mutant hyperphenylalaninemia gene would be a modified hydroxylase subunit. a' or P'. The hydroxylase in homozygous patients would then have the structure a'P or a@' (genotype A'A'BB or AAB'B'); these mutant dimers would have 5? of the normal hydroxylase activity. If the parents are simple heterorygotes (genotype A'ABB or AAB'B), their tissues would have equal amounts of two types of enzyme molecules: cup and N'P for the first genotype, and a@ and cup' for the second, and their hydroxylase activity would be expected to be about 50% of normal. T o explain the present finding that parents of hyperphenylalaninemic patients have an average of 10% of the normal activity, one must nssuliie nonrandom combination of the subunits (leading to selective formation of 0'8 or a@' mutant dimers) or more rapid synthesis (or slower degradation) of the mutant subunit compared with that of the normal subunits; either situation could lead to a preponderance of mutant dimers over the normal. full\. active dimers.
, ,
These arguments are based, in part, on our finding (as mentioned previously), that phenylalanine hydroxylase is composed of nonidentical subunits. It is possible that the enzyme is a multimer of identical subunits, the observed physical differences being caused by partial proteolysis of some of them during the isolation procedure. In this case. the analogous model of negative intraallelic complementation would lead to the same conclusions for the hydroxylase activity in heterozygotes.
If the active form of the hydroxylase were the tetramer (tu,P,), the same line of reasoning would lead to the prediction that the parents would have a minimum of about 29% of the normal hydroxylase activity (i.e.. for the case in which the a subunit is the modified one, their tissues u~ould contain three tj,pes of enzyme molecules, a,@,, ~C Y ' @~, and cu',P,, constituting. respectively. 25, 50, and 25%) of the hydroxylase population. If the presence of even a single mutant subunit. a ' , in the tetrnmer led to an enryme with only 5% of the normal catlaytic activity, three-fourths of the molecules would have 5% and one-fourth would have 100% of the hydroxylase activity, giving an average of 297) of the normal activity for this population of enzyme molecules).
Although we have not measured the hepatic phenylalanine hydroxylase levels in heterozygotes for classic PKU (i.e.. parents of patients with P K U ) , it seems likely that they, too, will be found to have less than 50% of the normal activity. The basis for this prediction is the observation that the ratio of plasma phenylalanine to tyrosine, a reflection of in vivo phenylalanlne hydroxylase activity, is similarly elevated for parents of classic PKU patients and for parents of hyperphenylalaninemia patients (9) . However, even though PKU homorygotes have a Far greater deficit in phenylalanine hydroxylase activity (0.27% of normal activity ( 5 ) ) than do hyperphenylulanirie~ni:~ patients, it should be evident from the models that have been discussed above that there need he no strict correlation between hydroxjlase activity in homorypotes and in hetero~ygotes; i.r.. classic PKU heterorygotes could well have higher hydroxylase activity t h~t n hypcrphenylal:tninemia heterorygotes.
A rigorous test of the validity of the foregoing conclusions must await further studies on the structure ofthe normal and the mutant enrymes and the availability of additional biops! samples.
S U M M A R Y
Patients with hyperphenylalunineriiiu have about 5% of the normal activity of hepatic phenylalanine hydroxylase, whereas their parents, presumed heterozygotes, have :In average of 10' 7c of the normal activity. These results can be explained by the multimeric structure of the hydroxylase.
